Article Information
vol. 10 no. 436
- Received for publication September 15, 2017
- Accepted for publication March 23, 2018
- .
Author Information
- Christian Chabannon1,*,
- Jurgen Kuball2,
- Attilio Bondanza3,
- Francesco Dazzi4,
- Paolo Pedrazzoli5,
- Antoine Toubert6,
- Annalisa Ruggeri7,8,
- Katharina Fleischhauer9 and
- Chiara Bonini10,*
- 1Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer, Université d’Aix-Marseille, INSERM CBT 1409, Centre d’Investigations Cliniques en Biothérapie, F-13009 Marseille, France.
- 2Laboratory of Translational Immunology and Department of Hematology, UMC Utrecht, 3508GA Utrecht, Netherlands.
- 3Innovative Immunotherapies Unit, Division of Immunology, Transplantation and Infectious Diseases, University Vita-Salute San Raffaele and Ospedale San Raffaele Scientific Institute, 20132 Milan, Italy.
- 4Division of Cancer Studies, King’s College London, London SE5 9NU, UK.
- 5Fondazione IRCCS Policlinico San Matteo, Medical Oncology Unit, Department of Oncology and Precision Medicine, 27100 Pavia, Italy.
- 6Université Paris Diderot, Institut Universitaire d’Hématologie, INSERM U1160; Laboratoire d’Immunologie et Histocompatibilité, Hôpital Saint-Louis, AP-HP, F-75010 Paris, France.
- 7Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine, AP-HP, Paris, France.
- 8Eurocord-Monacord, Hôpital Saint Louis, F-75011 Paris, France.
- 9Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.
- 10Experimental Hematology Unit, Division of Immunology, Transplantation and Infectious Diseases, University Vita-Salute San Raffaele and Ospedale San Raffaele Scientific Institute, 20132 Milan, Italy.
- ↵*Corresponding author. Email: bonini.chiara{at}hsr.it (C.B.); chabannonc{at}ipc.unicancer.fr (C.C.)